Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

33results about How to "Retain pharmacological activity" patented technology

Ganoderma lucidum refined polysaccharides with significant assistant antitumor activity and preparation method and application of ganoderma lucidum refined polysaccharides

ActiveCN107602719AGood clarificationDisappearance and reduction of pharmacological activityChemical industryAntineoplastic agentsUltrafiltrationFiltration
The invention relates to ganoderma lucidum refined polysaccharides with significant assistant antitumor activity and a preparation method and application of the ganoderma lucidum refined polysaccharides. The refined polysaccharides is heteropolysaccharide which is mainly prepared from mannose, glucosamine, glucuronic acid, glucose, galactose, xylose and fucose in a molar ratio of (3 to 4) to 1 to(1.3 to 1.7) to (56 to 65) to (4 to 6) to (1.3 to 1.8) to (2.5 to 3.5), the absolute purity is greater than 52%, the weight average molecular weight is 7500-8500D, and the molecular weight distribution index is 1.3 to 1.5. The preparation method comprises the following steps of dynamically extracting by hot water, coarsely filtering to remove residues, carrying out fine filtration and clarifying,deproteinizing and decoloring by in-series resin beds, concentrating and removing impurities by an ultrafiltration membrane, and carrying out spray-drying or alcohol precipitation air drying. The method is intelligent and energy-saving, can solve industrial difficult problems, and has significant large scale advantage and good product safety, effectiveness, controllability and stability. The polysaccharides have significant functional activity in assisting in antitumor and are useful for the development of drugs for prevention and treatment of tumors and the development of food and health products in related fields.
Owner:GUANGDONG YUEWEI EDIBLE FUNGI TECH

Method for simultaneously extracting polysaccharide and flavone from phellinus igniarius sporophore cultivation waste

The invention relates to a waste treatment method, in particular to a method for simultaneously extracting polysaccharide and flavone from phellinus igniarius sporophore cultivation waste. The method includes the steps: drying the phellinus igniarius sporophore cultivation waste, crushing the dried phellinus igniarius sporophore cultivation waste to obtain dry phellinus igniarius sporophore cultivation waste powder, and mixing the day powder and alkaline ethanol solution; ultrasonically treating the mixed solution for 20-40 minutes, and filtering to obtain filter solution and residues; adding deionized water into the residues, uniformly mixing, adjusting a pH (potential of hydrogen) value to be 4-6 to obtain mixed solution, adding compound enzyme, performing enzymolysis at the temperature ranging from 45 DEG C to 55 DEG C, and centrifuging the enzymolysis solution to obtain supernatant solution and sediments; rotatably evaporating filter solution to remove ethyl alcohol, adding ethyl acetate, extracting, separating solution, and performing pressure reduction, concentration and drying for upper layer solution to obtain phellinus igniarius sporophore flavone; performing pressure reduction and concentration for the obtained supernatant solution by the aid of a rotary evaporator, and performing alcohol precipitation and centrifugation to obtain supernatant solution and sediments. The sediments are phellinus igniarius sporophore polysaccharide.
Owner:淳安千岛湖桑都食用菌专业合作社

Preparation method and application of biologically-fermented Chinese angelica root oil

The invention aims to provide a preparation method and application of biologically-fermented Chinese angelica root oil. The preparation method comprises the following steps: performing superfine grinding on Chinese angelica root at a low temperature; performing wall breaking under increased pressure; adding a composite biological preparation for performing composite hydrolysis and fermentation; extracting fermented Chinese angelica root volatile oil A by means of water vapor distillation; performing suction filtration; adding filter residue into ethyl acetate, and heating and pressurizing to perform circular extraction of the Chinese angelica root oil; performing suction filtration and concentration, and removing a solvent to obtain Chinese angelica root oil B; compounding the Chinese angelica root oil A and the Chinese angelica root oil B to obtain the biologically-fermented Chinese angelica root oil. The biologically-fermented Chinese angelica root oil has the advantages of naturallycompounding natural smell such as the medicinal smell and of the Chinese angelica root and fresh fruit smell, lowering irritation and improving the fragrance quality, along with higher free radial scavenging capability and high oxidation resistance. When the biologically-fermented Chinese angelica root oil is applied to cigarettes, the biologically-fermented Chinese angelica root oil has abundantand natural fragrance, medicinal smell, fresh smell, fruit smell and fermentation smell, is coordinated with smoke, makes the smoke smell become clear, has the effects of resisting inflammation, relieving pain and asthma, improving laryngeal comfort degree, and overcomes the defects of over-strong medicinal smell, higher irritation and presence of offensive odor in the Chinese angelica root.
Owner:HUBEI CHINA TOBACCO IND

Ultrasonic extraction method of Acanthopanax giraldii polysaccharide

The invention provides an ultrasonic extraction method of Acanthopanax giraldii polysaccharide, belonging to the field of preparation of traditional Chinese medicines. The method comprises the following steps: drying Acanthopanax giraldii at 70-80 DEG C, and pulverizing by a pulverizer; immersing Acanthopanax giraldii in water in a weight ratio of 1:(20-22), extracting Acanthopanax giraldii polysaccharide under the auxiliary action of ultrasonic, and filtering to obtain an extract; concentrating the extract under reduced pressure to 1 / 10-1 / 12 of the original volume, adding trichloroacetic acid, sufficiently dissolving, standing for 10-12 hours, and filtering to collect the filtrate; adding ethanol into the filtrate, sufficiently stirring, standing and collecting a precipitate; and redissolving in water, and carrying out freeze-drying to obtain the Acanthopanax giraldii polysaccharide. The traditional method mostly adopts a boiling water extraction process, has the defects of high energy consumption and low extraction efficiency, easily destroys the polysaccharide structure, and influences the biological functions of the polysaccharide. The method can obviously enhance the polysaccharide extraction rate, and has the advantages of shorter extraction time and low energy consumption; and the obtained Acanthopanax giraldii polysaccharide has an obvious action on improving hypoimmunity caused by chemotherapeutic drugs.
Owner:WEIFANG MEDICAL UNIV

Edaravone pharmaceutical co-crystal and preparation method thereof

The invention belongs to the technical field of organic pharmaceutical co-crystals and particularly relates to a novel edaravone pharmaceutical co-crystal and a preparation method thereof. The edaravone pharmaceutical co-crystal takes edaravone as an active ingredient of the medicine and beta-cyclodextrin as a co-crystal formation; a basic structure unit of the edaravone pharmaceutical co-crystal consists of an edaravone molecule, a beta-cyclodextrin molecule and 10.5 water molecules, wherein a carbonyl oxygen atom and an amido nitrogen atom in the edaravone molecule are taken as a hydrogen bonding acceptor and hydroxyl in the beta-cyclodextrin molecule is taken as a hydrogen bonding donor to form two different intermolecular hydrogen bonds, and the antioxygenation of the edaravone is mainly exerted through clearing free radicals and inhibiting lipid peroxidation so as to inhibit the oxidative damage of brain cells, vascular endothelial cells and nerve cells. The co-crystal prepared by the invention keeps the pharmacological activity of the edaravone, and the solubility, the stability and the bioavailability are all remarkably improved. The result of the solubility test shows that the solubility of the pharmaceutical co-crystal is 6 times that of the edaravone.
Owner:ZHEJIANG CHINESE MEDICAL UNIVERSITY

GLP-1R/GCGR/GIPR triple receptor agonist and application thereof

ActiveCN114437181APromote secretionGood hypoglycemic biological activityPeptide-nucleic acidsSenses disorderAppetite regulationLipolysis
The invention discloses a GLP-1R/GCGR/GIPR triple receptor agonist and application of the GLP-1R/GCGR/GIPR triple receptor agonist. The polypeptide compound provided by the invention has a parent peptide represented by the following amino acid sequence: H < X > a < 1 > < X > a < 2 > < Glu3-Gly4 < X > a < 5 >-Phe6 < X > a < 7 > < X > a < 8 >-Asp9 < Val < 10 > < X > a < 11 >-Ser12 < X > a < 13 > Leu14 < Glu15 < Gly16 < Gln < 17 >-X < aa < 18 >-Ala19 < X > a < 20 >-Glu21 < 1 >-Phe22 < Val < 27 >-X < aa < 18 >-Ala24 < Trp < 25 >-Leu26 < Val < 27 >-X < aa < 28 >-Gly29 < Arg < 30 >-Gly31 The polypeptide compound has the functions of reducing blood sugar, promoting insulin secretion, controlling appetite, regulating metabolic disorder, controlling lipolysis, improving heat consumption and the like, has the characteristics of good stability, high biological activity and the like, can be used as a GLP-1R/GCGR/GIPR triple receptor agonist, is expected to be used as a new-generation medicine for preventing or treating diabetes and obesity, and has wide application prospects. The traditional Chinese medicine composition can be used for preventing or treating diseases such as non-alcoholic fatty liver diseases, hyperlipidemia, arteriosclerosis and the like.
Owner:深圳深创生物药业有限公司

Method for simultaneously extracting polysaccharide and flavone from stems and leaves of radix tetrastigme

The invention discloses a method for simultaneously extracting polysaccharide and flavone from stems and leaves of Tetrastigma hemsleyanum. The method comprises the following steps: drying and crushing the stems and leaves of the Tetrastigma hemsleyanum to obtain dry powder of the stems and leaves of the Tetrastigma hemsleyanum; mixing the Tetrastigma hemsleyanum stem and leaf dry powder with an acidic ethanol solution to obtain a mixed solution; carrying out water bath treatment on the mixed solution, and performing centrifuging to obtain a first supernatant and a first residue; uniformly mixing the first residue with deionized water, carrying out microwave extraction, and centrifuging the extract to obtain a second supernatant and a second residue; combining and mixing the first supernatant and the second supernatant, performing rotary evaporation to remove ethanol, adding NaCl to be a saturation state, adding an ethyl acetate solution for extraction, and performing liquid separation; concentrating the supernatant under reduced pressure and performing drying to obtain tetrastigma hemsleyanum flavone, and performing dialyzing, reduced-pressure concentrating and precipitating on the subnatant to obtain tetrastigma hemsleyanum polysaccharide. According to the method, the production process is simplified, safety and reliability are achieved, the yield is high, the biological activity of polysaccharide and flavone in the Tetrastigma hemsleyanum stems and leaves is well reserved, and the economic value is high.
Owner:浙江武义汇美中药材有限公司

A kind of Ganoderma lucidum dendrobium suspension and preparation method thereof

A Ganoderma lucidum dendrobium suspension and a preparation method thereof. A ganoderma dendrobium suspension, the mass percentage of each component is: 20-30% of ganoderma extract powder, 65-75% of dendrobium candidum extract, 4.98-4.99% of water, 0.01-0.02% of sweetener, the The preparation method of the suspension: Ganoderma lucidum fruiting body pulverization, supercritical CO 2 Extract to remove fat-soluble impurities, extract with ethanol, filter, concentrate and dry and ultrafinely pulverize to obtain Ganoderma lucidum extract powder; freeze-dry Dendrobium candidum, extract at low temperature, and centrifuge the extract to obtain Dendrobium candidum extract; Ganoderma lucidum extract powder Suspending with Dendrobium candidum extract, dissolving the sweetener in water, mixing the water with the suspension, and aseptically filling to obtain a finished product. The content of Ganoderma lucidum triterpene acid in the finished product is ≥30mg / mL, and the content of polysaccharides is ≥35mg / mL. The invention uses Ganoderma lucidum as the functional component and antibacterial agent, and Dendrobium candidum as the functional component, suspending agent and corrective agent, and the finished product has good stability, good taste and no bitter taste.
Owner:福建仙芝楼生物科技有限公司 +1

A method for simultaneously extracting polysaccharides and flavonoids from Phellinus Phellinus cultivation waste

The invention relates to a waste treatment method, in particular to a method for simultaneously extracting polysaccharide and flavone from phellinus igniarius sporophore cultivation waste. The method includes the steps: drying the phellinus igniarius sporophore cultivation waste, crushing the dried phellinus igniarius sporophore cultivation waste to obtain dry phellinus igniarius sporophore cultivation waste powder, and mixing the day powder and alkaline ethanol solution; ultrasonically treating the mixed solution for 20-40 minutes, and filtering to obtain filter solution and residues; adding deionized water into the residues, uniformly mixing, adjusting a pH (potential of hydrogen) value to be 4-6 to obtain mixed solution, adding compound enzyme, performing enzymolysis at the temperature ranging from 45 DEG C to 55 DEG C, and centrifuging the enzymolysis solution to obtain supernatant solution and sediments; rotatably evaporating filter solution to remove ethyl alcohol, adding ethyl acetate, extracting, separating solution, and performing pressure reduction, concentration and drying for upper layer solution to obtain phellinus igniarius sporophore flavone; performing pressure reduction and concentration for the obtained supernatant solution by the aid of a rotary evaporator, and performing alcohol precipitation and centrifugation to obtain supernatant solution and sediments. The sediments are phellinus igniarius sporophore polysaccharide.
Owner:淳安千岛湖桑都食用菌专业合作社

Traditional Chinese medicine spray for helping sleep and preparation method and application thereof

InactiveCN112245523AImprove extraction efficiencyHigh efficiency and high extraction efficiencyNervous disorderAerosol deliveryLavandulaWolfiporia extensa
The invention relates to the technical field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine spray for helping sleep and a preparation method and application thereof. The traditional Chinese medicine spray is prepared from the following raw materials in parts by weight: 1 to 5 parts of semen ziziphi spinosae extract, 1 to 6 parts of caulis polygoni multiflori extract, 0.1 to 2 parts of poria cocos extract, 3 to 6 parts of lily bulb extract, 0.1 to 5 parts of ganoderma extract, 0.3 to 0.8 part of lavender extract, and 60 to 80 parts of water. The traditional Chinese medicine spray has the advantages that the semen ziziphi spinosae extract, the caulis polygoni multiflori extract, the poria cocos extract, the radix polygalae extract, the longan extract, the poria cocos extract, the ganoderma extract and the like are prepared into the traditional Chinese medicine spray according to the specific proportional ratio, the different pharmacological activities of the traditional Chinese medicine extracts are fully utilized, the traditional Chinese medicine extracts are mutually dependent and promoted, and the excellent technical effect of promoting sleep is realized; and the traditional Chinese medicine extracts are prepared into the external spray, and are sprayed to the Baihui acupoint at the top of head, so that the effective components inthe traditional Chinese medicine extracts can be absorbed in a transdermal way, and the problems of bad odor, bitter taste and difficulty in drinking of the traditional Chinese medicine are solved.
Owner:河北爱吾乐生物科技有限公司

A refined polysaccharide of Ganoderma lucidum fruiting body with significant auxiliary anti-tumor activity and its preparation method and application

ActiveCN107602719BGood clarificationDisappearance and reduction of pharmacological activityChemical industryAntineoplastic agentsBiotechnologyUltrafiltration
The invention relates to ganoderma lucidum refined polysaccharides with significant assistant antitumor activity and a preparation method and application of the ganoderma lucidum refined polysaccharides. The refined polysaccharides is heteropolysaccharide which is mainly prepared from mannose, glucosamine, glucuronic acid, glucose, galactose, xylose and fucose in a molar ratio of (3 to 4) to 1 to(1.3 to 1.7) to (56 to 65) to (4 to 6) to (1.3 to 1.8) to (2.5 to 3.5), the absolute purity is greater than 52%, the weight average molecular weight is 7500-8500D, and the molecular weight distribution index is 1.3 to 1.5. The preparation method comprises the following steps of dynamically extracting by hot water, coarsely filtering to remove residues, carrying out fine filtration and clarifying,deproteinizing and decoloring by in-series resin beds, concentrating and removing impurities by an ultrafiltration membrane, and carrying out spray-drying or alcohol precipitation air drying. The method is intelligent and energy-saving, can solve industrial difficult problems, and has significant large scale advantage and good product safety, effectiveness, controllability and stability. The polysaccharides have significant functional activity in assisting in antitumor and are useful for the development of drugs for prevention and treatment of tumors and the development of food and health products in related fields.
Owner:GUANGDONG YUEWEI EDIBLE FUNGI TECH

Preparation method and application of metformin carbon dots

The invention discloses a preparation method and application of metformin carbon dots, and relates to the technical field of medicine preparation, the method comprises the following steps: S1, respectively dissolving metformin hydrochloride and citric acid in deionized water; s2, transferring the two mixed solutions into a high-pressure reaction kettle system; after the reaction is finished, taking out a reaction system, cooling to room temperature, and collecting to obtain a reaction solution; s3, filtering the reaction solution by adopting a filter membrane, and collecting to obtain filtrate; and S4, removing unreacted small molecular compounds from the filtrate in the step S3 by using a dialysis bag with the molecular weight cut-off of 500Da, and finally freeze-drying to obtain a metformin carbon dot freeze-dried sample. In the preparation process of the metformin carbon dots, the basic pharmacodynamic structure of functional small molecules is not damaged, and the pharmacological activity of the functional small molecules can still be reserved, so that the metformin carbon dots can promote neural stem cells to differentiate into neuronal cells, and compared with metformin, citric acid and a mixture of the metformin and the citric acid which have the same concentration in theory, the metformin carbon dots have a better neuronal differentiation promoting proportion.
Owner:JILIN UNIV

A kind of edaravone drug co-crystal and preparation method thereof

The invention belongs to the technical field of organic pharmaceutical co-crystals and particularly relates to a novel edaravone pharmaceutical co-crystal and a preparation method thereof. The edaravone pharmaceutical co-crystal takes edaravone as an active ingredient of the medicine and beta-cyclodextrin as a co-crystal formation; a basic structure unit of the edaravone pharmaceutical co-crystal consists of an edaravone molecule, a beta-cyclodextrin molecule and 10.5 water molecules, wherein a carbonyl oxygen atom and an amido nitrogen atom in the edaravone molecule are taken as a hydrogen bonding acceptor and hydroxyl in the beta-cyclodextrin molecule is taken as a hydrogen bonding donor to form two different intermolecular hydrogen bonds, and the antioxygenation of the edaravone is mainly exerted through clearing free radicals and inhibiting lipid peroxidation so as to inhibit the oxidative damage of brain cells, vascular endothelial cells and nerve cells. The co-crystal prepared by the invention keeps the pharmacological activity of the edaravone, and the solubility, the stability and the bioavailability are all remarkably improved. The result of the solubility test shows that the solubility of the pharmaceutical co-crystal is 6 times that of the edaravone.
Owner:ZHEJIANG CHINESE MEDICAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products